SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalImmunomedics (IMMU) - moderated


Previous 10 Next 10 
From: WawaDoc8/20/2019 5:26:24 PM
4 Recommendations   of 58472
 
I know I state the obvious. As long as there have been markets, there have been swindlers. For the 1,000s of years we have markets, the brightest people in the industry have been snookered. There are are some good crooks out there, now, and very sharp people getting it. Down a dollar today, someone made some bucks. I have a lot of this stock, I believe in the science. But I have said before the science is passing IMMU. I am most distressed by the friends and patients, I have lost to the greed and incompetence of our system. Is time to rethink how we do medicine In the US

Share RecommendKeepReplyMark as Last Read


From: EagleRare8/21/2019 10:18:21 AM
   of 58472
 
Interesting share price chart. If you go for that stuff, we are at an inflection point.

finance.yahoo.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: rodneyh078/21/2019 10:41:41 AM
   of 58472
 
Look and sound familiar...... “surprised “:

We are very surprised to have received the complete response letter this afternoon,” Sarepta CEO Dough Ingram said in a statement released by the company. “Over the entire course of its review, the Agency did not raise any issues suggesting the non-approvability of golodirsen, including the issues that formed the basis of the complete response letter.”

Share RecommendKeepReplyMark as Last Read


To: EagleRare who wrote (52168)8/21/2019 12:11:03 PM
From: plhky3465
   of 58472
 
which way we going from here????

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: plhky3465 who wrote (52170)8/21/2019 1:58:36 PM
From: EagleRare
   of 58472
 
I thought the share price would resolve itself in that triangular channel in October on BLA resubmission. Maybe that DS-1062 data release will materially impact the share price today though. We'll find out soon.

Share RecommendKeepReplyMark as Last Read


To: plhky3465 who wrote (52170)8/21/2019 2:16:09 PM
From: sysiphus
1 Recommendation   of 58472
 
The stock will drop to $13.46 by the end of August; then rise to $15.71 by September 15th; then rise to $19.20 by October 10th; and then close the year at $23.80.

Share RecommendKeepReplyMark as Last Read


To: JJINV who wrote (52152)8/21/2019 2:54:28 PM
From: Longtimeinvestor
   of 58472
 
Is the 1062 data being released today. If so, does anyone know what time?

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Longtimeinvestor who wrote (52173)8/21/2019 3:54:18 PM
From: ladyPI
   of 58472
 
I’m told secondhand 5 pm

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: ladyPI who wrote (52174)8/21/2019 4:03:21 PM
From: JoeP1
1 Recommendation   of 58472
 
I believe 5:30pm Eastern

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: JoeP1 who wrote (52175)8/21/2019 5:41:05 PM
From: KeeptheFaith
1 Recommendation   of 58472
 
finance.yahoo.com

no information other than oral presentation date/times.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10